the future of daratumumab in multiple myeloma
Published 1 year ago • 1.1K plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
1:53
the future of multiple myeloma treatment
-
1:54
the future of multiple myeloma treatment
-
1:29
the future of adcs in treating multiple myeloma
-
2:49
trimm-2 update: talquetamab daratumumab in r/r multiple myeloma
-
4:22
future maintenance therapy approaches for multiple myeloma
-
6:23
how long will i live with multiple myeloma and is there a cure?
-
4:04
the future of myeloma treatment and the possibility of cure
-
1:22
daratumumab and dexamethasone in the treatment of patients with myeloma and severe renal impairment
-
4:03
novel technologies in multiple myeloma and how these are changing the field
-
2:09
the candor trial extended follow-up: daratumumab for r/r myeloma
-
3:10
is there a benefit to rituximab maintenance after first-line bendamustine-rituximab for mcl?
-
2:36
approaching a myeloma population becoming increasingly resistant to daratumumab
-
3:23
a bright future for multiple myeloma
-
5:06
advances in immunotherapy for multiple myeloma and future outlooks
-
3:56
iv daratumumab in r/r myeloma: bodyweight analysis
-
1:53
canova trial: vendex versus pomdex in patients with r/r multiple myeloma
-
0:46
future developments in myeloma treatment
-
2:36
the price of new innovation for the treatment of multiple myeloma
-
5:07
daratumumab in the management of al amyloidosis
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
5:36
daratumumab shows remarkable benefit in relapsed or refractory multiple myeloma in the pollux trial
-
2:17
moving towards fixed-duration treatment in multiple myeloma